Randomization is not the (Only) Answer: A Plea for Structured Objective Evaluation of Endoscopic Therapy

 

 Buy Article Permissions and Reprints

Endoscopic therapy clearly has a primary role in many clinical conditions (such as dysphagia, obstructive jaundice, bleeding, and colonic polyps). There is much less certainty about the role of endoscopy in many other clinical contexts (e. g. management of chronic pancreatitis). Randomization is the gold standard for evaluation of competing therapies. Unfortunately, there are many difficulties in mounting meaningful randomized controlled trials of endoscopic methods. Many have been done, but few have provided us with real practical answers. This article argues that the evidence we need to advise patients is often better obtained through very stringent observational studies, provided that all necessary data elements are defined and documented and independent objective arbiters (referees) are fully involved in the process.

References

• 1 Cotton P B. Therapeutic gastrointestinal endoscopy. Problems in proving efficacy.  N Engl J Med. 1992;  326 1626-1628
  PubMedGoogle Scholar
• 2 Cotton P B. Outcomes of endoscopy procedures: struggling towards definitions.  Gastrointest Endosc. 1994;  40 514-518
  CrossrefPubMedGoogle Scholar
• 3 Cotton P B. Endoscopy in crisis. The challenge of new technology.  Gastrointest Endosc. 1997;  46 189-191
  PubMedGoogle Scholar
• 4 Smith A C, Dowsett J F, Russell R CG, et al. Randomised trial of endoscopic stenting versus surgical bypass in malignant low bile duct obstruction.  Lancet. 1994;  344 1655-1660
  CrossrefPubMedGoogle Scholar
• 5 McDermott W M, Amorosino C S. Sounding board of mice but not men.  N Engl J Med. 1991;  324 1585-1589
  PubMedGoogle Scholar
• 6 Passamani E. Clinical trials - are they ethical?.  N Engl J Med. 1991;  324 1589-1592
  PubMedGoogle Scholar
• 7 Pollock A V. Surgical evaluation at the crossroads.  Br J Surg. 1993;  80 964-966
  PubMedGoogle Scholar
• 8 Lans J I, Geenen J E, Johanson J F, et al. Endoscopic therapy in patients with pancreas divisum and acute pancreatitis: a prospective, randomized, controlled clinical trial.  Gastrointest Endosc. 1992;  38 430-434
  PubMedGoogle Scholar
• 9 Warshaw A L, Banks P A, Fernandez-del Castillo C. AGA technical review on treatment of pain in chronic pancreatitis.  Gastroenterology. 1998;  115 763-764
  PubMedGoogle Scholar
• 10 Cotton P B, Jowell P S, Baillie J, et al. Spectrum of complications after diagnostic ERCP and effect of comorbidities.  Gastrointest Endosc. 1994;  40 (2) A16
  PubMedGoogle Scholar
• 11 Keat A S. The ASA classification of physical status: a recapitulation.  Anesthesiology. 1978;  49 233-237
  PubMedGoogle Scholar
• 12 Iezzoni L I, Ash A S, Shwartz M, et al. Predicting who dies depends on how severity is measured: implications for evaluation patient outcomes.  Ann Int Med. 1995;  123 763-770
  PubMedGoogle Scholar
• 13 Thomas J W, Ashcraft M LF. Measuring severity of illness: six severity systems and their ability to explain cost variations.  Inquiry. 1991;  28 39-55
  PubMedGoogle Scholar
• 14 Charlson M E, Pompei P, Ales K L, Mackenzie C R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.  J Chron Dis. 1987;  40 373-383
  CrossrefPubMedGoogle Scholar
• 15 Cotton P B, Schmitt C. Quality of life in palliative management of malignant obstructive jaundice.  Scand J Gastroenterol. 1993;  28 Suppl. 199 44-46
  PubMedGoogle Scholar
• 16 Ware J E, Sherborne C D. The MOS 36-item short-form health survey (SF-36): I. Conceptual framework and item selection.  Med Care. 1992;  30 473-483
  CrossrefPubMedGoogle Scholar
• 17 Eypasch E, Williams J I, Wood-Dauphinee S, et al. Gastrointestinal quality of life index: development, validation and application of a new instrument.  Br J Surg. 1995;  82 216-222
  Google Scholar
• 18 Palesch Y Y, Herbert R L, Tarnasky P R, et al. DDQ-15: A health-related quality of life instrument for patients with digestive disorders. Amer J Gastro Submitted 1999
  Google Scholar
• 19 Irvine E J, Feagan B, Rochon J, et al. Quality of life: a valid and reliable measure of therapeutic efficacy in the treatment of inflammatory bowel disease.  Gastroenterology. 1994;  106 287-296
  PubMedGoogle Scholar

P. B. Cotton, M.D., F.R.C.P.

Digestive Disease Center Medical University of South Carolina

96 Jonathan Lucas Street Suite 210 Clinical Science Building P.O. Box 250327 Charleston, SC 29425 USA

Fax: Fax:+ 1-843-792-4184

Email: E-mail:cottonp@musc.edu